Diflorasone diacetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for diflorasone diacetate and what is the scope of freedom to operate?
Diflorasone diacetate
is the generic ingredient in five branded drugs marketed by Ani Pharms, Avondale Pharms, Taro, Pfizer, Taro Pharms North, Rising, Sciegen Pharms Inc, and The J Molner, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for diflorasone diacetate. Five suppliers are listed for this compound.
Summary for diflorasone diacetate
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 8 |
| NDAs: | 13 |
| Drug Master File Entries: | 3 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Patent Applications: | 6,273 |
| Drug Prices: | Drug price trends for diflorasone diacetate |
| What excipients (inactive ingredients) are in diflorasone diacetate? | diflorasone diacetate excipients list |
| DailyMed Link: | diflorasone diacetate at DailyMed |
Pharmacology for diflorasone diacetate
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for diflorasone diacetate
US Patents and Regulatory Information for diflorasone diacetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | PSORCON E | diflorasone diacetate | OINTMENT;TOPICAL | 017994-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Avondale Pharms | DIFLORASONE DIACETATE | diflorasone diacetate | OINTMENT;TOPICAL | 075374-001 | Apr 27, 1999 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ani Pharms | DIFLORASONE DIACETATE | diflorasone diacetate | CREAM;TOPICAL | 076263-001 | Dec 20, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| The J Molner | DIFLORASONE DIACETATE | diflorasone diacetate | OINTMENT;TOPICAL | 210753-001 | Jun 12, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | PSORCON | diflorasone diacetate | OINTMENT;TOPICAL | 019260-001 | Aug 28, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | FLORONE E | diflorasone diacetate | CREAM;TOPICAL | 019259-001 | Aug 28, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for diflorasone diacetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | PSORCON E | diflorasone diacetate | OINTMENT;TOPICAL | 017994-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | FLORONE | diflorasone diacetate | CREAM;TOPICAL | 017741-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | PSORCON | diflorasone diacetate | OINTMENT;TOPICAL | 019260-001 | Aug 28, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | FLORONE E | diflorasone diacetate | CREAM;TOPICAL | 019259-001 | Aug 28, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
